Literature DB >> 6632079

Pharmacokinetics of chloramphenicol in the neonatal horse.

G W Brumbaugh, R J Martens, H D Knight, M T Martin.   

Abstract

Chloramphenicol sodium succinate was administered as an intravenous bolus (50 mg/kg) to eight foals which weighed 49-57 kg (mean +/- 1 standard deviation = 53.19 +/- 2.66) each, and were 1-9 days (4.5 +/- 2.56) of age. The drug was rapidly distributed and followed first-order elimination. Mean pharmacokinetic values were: zero-time serum concentration (C0) = 36.14 microgram/ml (+/- 14.80); apparent specific volume of distribution (Vd) = 1.614 1/kg (+/- 0.669); and elimination rate constant (K) = 0.7295 h-1 (+/- 0.3066) which corresponds to a biological half-life (t1/2) = 0.95 h. These values do not differ greatly from those reported for adult horses and ponies. A suspension of chloramphenicol was administered by nasogastric tube (50 mg/kg) to a second group of seven foals which weighed 49 to 57 kg (51.34 +/- 2.82) each and were 1 to 7 days (4.43 +/- 1.90) of age. A mean peak serum chloramphenicol concentration of 23.97 microgram/ml (+/- 7.06) was achieved 1.14 h (+/- 0.63) after administration. The bioavailability of this preparation was 83.27 percent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6632079     DOI: 10.1111/j.1365-2885.1983.tb00467.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  3 in total

1.  Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses.

Authors:  D F Gerken; R A Sams
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

2.  Pharmacokinetic study of chloramphenicol in calves using sensitive gas-liquid chromatographic analysis.

Authors:  N Watson; W D Black
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

3.  The influence of age on the pharmacokinetics of aditoprim in pigs after intravenous and oral administration.

Authors:  J L Riond; P Müller; M Wanner
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.